Form 4: Sylvamo Corp Executive Rodrigo Davoli Reports Acquisition of Dividend Equivalent Units
SEC Form 4 Filing
Rodrigo Davoli, SVP & GM of North America at Sylvamo Corp, reports the acquisition of dividend equivalent units related to previously granted restricted stock units.
Summary
- On April 29, 2025, Rodrigo Davoli, SVP & GM of North America at Sylvamo Corp, acquired 45.0923 dividend equivalent units (DEUs).
- These DEUs are accrued on restricted stock units (RSUs) previously granted to Davoli.
- The DEUs will vest and be settled under the same terms as the original RSUs, with each DEU representing the right to receive one share of Sylvamo Corporation common stock.
- Following the transaction, Davoli directly owns 567.8753 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an executive's acquisition of dividend equivalent units, which is a neutral event.
Future Outlook
The dividend equivalent units will vest and be settled on the same terms and conditions as the original RSUs to which they relate.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the holdings and transactions of company executives. It is standard practice for publicly traded companies to report such transactions to the SEC.
Key Dates
| Date | Description |
|---|---|
| 04/29/2025 | Date of transaction: Acquisition of dividend equivalent units |
| 05/01/2025 | Date of Form 4 filing |
Keywords
Sylvamo Corp, Rodrigo Davoli, dividend equivalent units, DEUs, restricted stock units, RSUs, Form 4, beneficial ownership, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.